Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by YAGUANG WENG
MicroRNA-522 Reverses Drug Resistance of Doxorubicin-Induced HT29 Colon Cancer Cell by Targeting ABCB5
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
miR-107 Promotes the Erythroid Differentiation of Leukemia Cells via the Downregulation of Cacna2d1
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Related publications
Curcumin Co-Treatment Sensitizes Multi-Drug Resistant Ht29 Colon Cancer Cell Line
Journal of Cancer Research and Immuno-Oncology
MicroRNA‑506‑3p Reverses Gefitinib Resistance in Non‑small Cell Lung Cancer by Targeting Yes‑associated Protein 1
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1
Oncology Letters
Cancer Research
Oncology
Doxorubicin Resistance Induces IL6 Activation in the Colon Cancer Cell Line LS180
Oncology Letters
Cancer Research
Oncology
Erratum To: MicroRNA-492 Reverses High Glucose-Induced Insulin Resistance in HUVEC Cells Through Targeting Resistin
Molecular and Cellular Biochemistry
Medicine
Clinical Biochemistry
Cell Biology
Molecular Biology
MicroRNA‑96 Expression Induced by Low‑dose Cisplatin or Doxorubicin Regulates Chemosensitivity, Cell Death and Proliferation in Gastric Cancer SGC7901 Cells by Targeting FOXO1
Oncology Letters
Cancer Research
Oncology
ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1
Cancer Management and Research
Oncology
microRNA-342-5p and miR-608 Inhibit Colon Cancer Tumorigenesis by Targeting NAA10
Oncotarget
Oncology
